The possibility to generate dopaminergic (DA) neurons from pluripotent stem cells represents an unlimited source of material for tissue engineering and cell therapy for neurodegenerative disease. We set up a protocol based on the generation of size-calibrated neurospheres for a rapid production (3 weeks) of a high amount of DA neurons (>60%) oriented toward a midbrain-like phenotype, characterized by the expression of FOXA2, LMX1A, tyrosine hydroxylase (TH), NURR1, and EN1. By using γ-secretase inhibitors and varying culture time of neurospheres, we controlled maturation and cellular composition of a three-dimensional (3D) engineered nervous tissue (ENT). ENT contained neurons and glial cells expressing various markers of maturity, such as synaptophysin, neuronal nuclei-specific protein (NeuN), and glial fibrillary acidic protein (GFAP), and were electrophysiologically active. We found that 3-week-old neurospheres were optimal to generate 3D tissue containing DA neurons with typical A9 morphology. ENT generated from 4-week-old neurospheres launched glial cell type since astrocytes and myelin could be detected massively at the expense of TH-immunoreactive neurons. All γ-secretase inhibitors were not equivalent; compound E was more efficient than DAPT in generating DA neurons. This DA tissue provides a tool for drug screening, and toxicology. It should also become a useful biomaterial for studies on Parkinson's disease.
Get full access to this article
View all access options for this article.
References
1.
OrlacchioA, BernardiG, OrlacchioA and MartinoS. (2010). Stem cells: an overview of the current status of therapies for central and peripheral nervous system diseases. Curr Med Chem, 17:595–608.
2.
DuttaRC and DuttaAK. (2009). Cell-interactive 3D-scaffold; advances and applications. Biotechnol Adv, 27:334–339.
3.
SubramanianA, KrishnanUM and SethuramanS. (2009). Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration. J Biomed Sci, 16:108.
4.
TibbittMW and AnsethKS. (2009). Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng, 103:655–663.
5.
BritoC, SimaoD, CostaI, MalpiqueR, PereiraCI, et al. (2012). 3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected]. Methods, 56:452–460.
6.
DewittDD, KaszubaSN, ThompsonDM and StegemannJP. (2009). Collagen I-matrigel scaffolds for enhanced Schwann cell survival and control of three-dimensional cell morphology. Tissue Eng Part A, 15:2785–2793.
7.
DruryJL and MooneyDJ. (2003). Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials, 24:4337–4351.
8.
MadisonR, da SilvaCF, DikkesP, ChiuTH and SidmanRL. (1985). Increased rate of peripheral nerve regeneration using bioresorbable nerve guides and a laminin-containing gel. Exp Neurol, 88:767–772.
9.
WellsMR, KrausK, BatterDK, BluntDG, WeremowitzJ, et al. (1997). Gel matrix vehicles for growth factor application in nerve gap injuries repaired with tubes: a comparison of biomatrix, collagen, and methylcellulose. Exp Neurol, 146:395–402.
10.
BorkenhagenM, ClemenceJF, SigristH and AebischerP. (1998). Three-dimensional extracellular matrix engineering in the nervous system. J Biomed Mater Res, 40:392–400.
11.
DillonGP, YuX, SridharanA, RanieriJP and BellamkondaRV. (1998). The influence of physical structure and charge on neurite extension in a 3D hydrogel scaffold. J Biomater Sci Polym Ed, 9:1049–1069.
12.
MahoneyMJ and AnsethKS. (2006). Three-dimensional growth and function of neural tissue in degradable polyethylene glycol hydrogels. Biomaterials, 27:2265–2274.
13.
Dubois-DauphinML, ToniN, JulienSD, CharvetI, SundstromLE, et al. (2010). The long-term survival of in vitro engineered nervous tissue derived from the specific neural differentiation of mouse embryonic stem cells. Biomaterials, 31:7032–7042.
14.
Preynat-SeauveO, SuterDM, TirefortD, TurchiL, VirolleT, et al. (2009). Development of human nervous tissue upon differentiation of embryonic stem cells in three-dimensional culture. Stem Cells, 27:509–520.
15.
ChambersSM, FasanoCA, PapapetrouEP, TomishimaM, SadelainM, et al. (2009). Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol, 27:275–280.
16.
KirkebyA, NelanderJ and ParmarM. (2012). Generating regionalized neuronal cells from pluripotency, a step-by-step protocol. Front Cell Neurosci, 6:64.
17.
BauwensCL, PeeraniR, NiebrueggeS, WoodhouseKA, KumachevaE, et al. (2008). Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. Stem Cells, 26:2300–2310.
18.
Bratt-LealAM, CarpenedoRL and Mc DevittTC. (2009). Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation. Biotechnol Prog, 25:43–51.
19.
HwangYS, ChungBG, OrtmannD, HattoriN, MoellerHC, et al. (2009). Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci U S A, 106:16978–16983.
20.
UngrinMD, JoshiC, NicaA, BauwensC and ZandstraPW. (2008). Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One, 3:e1565.
21.
OyaS, YoshikawaG, TakaiK, TanakaJI, HigashiyamaS, et al. (2009). Attenuation of Notch signaling promotes the differentiation of neural progenitors into neurons in the hippocampal CA1 region after ischemic injury. Neuroscience, 158:683–692.
22.
BorgheseL, DolezalovaD, OpitzT, HauptS, LeinhaasA, et al. (2010). Inhibition of notch signaling in human embryonic stem cell-derived neural stem cells delays G1/S phase transition and accelerates neuronal differentiation in vitro and in vivo. Stem Cells, 28:955–964.
23.
OishiK, KamakuraS, IsazawaY, YoshimatsuT, KuidaK, et al. (2004). Notch promotes survival of neural precursor cells via mechanisms distinct from those regulating neurogenesis. Dev Biol, 276:172–184.
24.
KriksS, ShimJW, PiaoJ, GanatYM, WakemanDR, et al. (2011). Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature, 480:547–551.
25.
BrennandKJ, SimoneA, JouJ, Gelboin-BurkhartC, TranN, et al. (2011). Modelling schizophrenia using human induced pluripotent stem cells. Nature, 473:221–225.
26.
FinkelsteinDI, StanicD, ParishCL, TomasD, DicksonK, et al. (2000). Axonal sprouting following lesions of the rat substantia nigra. Neuroscience, 97:99–112.
27.
KungL, ForceM, ChuteDJ and RobertsRC. (1998). Immunocytochemical localization of tyrosine hydroxylase in the human striatum: a postmortem ultrastructural study. J Comp Neurol, 390:52–62.
28.
BedardC, WallmanMJ, PourcherE, GouldPV, ParentA, et al. (2011). Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea. Parkinsonism Relat Disord, 17:593–598.
29.
DottoriM and PeraMF. (2008). Neural differentiation of human embryonic stem cells. Methods Mol Biol, 438:19–30.
30.
ZhangXQ and ZhangSC. (2010). Differentiation of neural precursors and dopaminergic neurons from human embryonic stem cells. Methods Mol Biol, 584:355–366.
31.
WatanabeK, UenoM, KamiyaD, NishiyamaA, MatsumuraM, et al. (2007). A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol, 25:681–686.
32.
ZhouJ, SuP, LiD, TsangS, DuanE, et al. (2010). High-efficiency induction of neural conversion in human ESCs and human induced pluripotent stem cells with a single chemical inhibitor of transforming growth factor beta superfamily receptors. Stem Cells, 28:1741–1750.
33.
FawcettJW, BarkerRA and DunnettSB. (1995). Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon. Exp Brain Res, 106:275–282.
34.
ChoiHK, WonL and HellerA. (1993). Dopaminergic neurons grown in three-dimensional reaggregate culture for periods of up to one year. J Neurosci Methods, 46:233–244.
35.
PardoB and HoneggerP. (2000). Differentiation of rat striatal embryonic stem cells in vitro: monolayer culture vs. three-dimensional coculture with differentiated brain cells. J Neurosci Res, 59:504–512.
36.
O'ConnorSM, StengerDA, ShafferKM, MaricD, BarkerJL, et al. (2000). Primary neural precursor cell expansion, differentiation and cytosolic Ca(2+) response in three-dimensional collagen gel. J Neurosci Methods, 102:187–195.
37.
FerriAL, LinW, MavromatakisYE, WangJC, SasakiH, et al. (2007). Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner. Development, 134:2761–2769.
38.
NakataniT, KumaiM, MizuharaE, MinakiY and OnoY. (2010). Lmx1a and Lmx1b cooperate with Foxa2 to coordinate the specification of dopaminergic neurons and control of floor plate cell differentiation in the developing mesencephalon. Dev Biol, 339:101–113.
39.
Garcia-YagueAJ, RadaP, RojoAI, Lastres-BeckerI and CuadradoA. (2013). Nuclear import and export signals control the subcellular localization of Nurr1 protein in response to oxidative stress. J Biol Chem, 288:5506–5517.
40.
Boldingh DebernardKA, MathisenGH and PaulsenRE. (2012). Differences in NGFI-B, Nurr1, and NOR-1 expression and nucleocytoplasmic translocation in glutamate-treated neurons. Neurochem Int, 61:79–88.
41.
OjedaV, FuentealbaJA, GalleguillosD and AndresME. (2003). Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat. J Neurosci Res, 73:686–697.
42.
HaapasaloA and KovacsDM. (2011). The many substrates of presenilin/gamma-secretase. J Alzheimers Dis, 25:3–28.
43.
YangMS, HongJS, KimST, LeeKY, ParkKW, et al. (2011). Among gamma-secretase substrates Notch1 alone is sufficient to block neurogenesis but does not confer self-renewal properties to neural stem cells. Biochem Biophys Res Commun, 404:133–138.
44.
OguraA, MorizaneA, NakajimaY, MiyamotoS and TakahashiJ. (2013). Gamma-secretase inhibitors prevent overgrowth of transplanted neural progenitors derived from human-induced pluripotent stem cells. Stem Cells Dev, 22:374–382.
45.
BertrandN, CastroDS and GuillemotF. (2002). Proneural genes and the specification of neural cell types. Nat Rev Neurosci, 3:517–530.
46.
BarberiT, BradburyM, DincerZ, PanagiotakosG, SocciND, et al. (2007). Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med, 13:642–648.
47.
PerrierAL, TabarV, BarberiT, RubioME, BrusesJ, et al. (2004). Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A, 101:12543–12548.
48.
ChungS, MoonJI, LeungA, AldrichD, LukianovS, et al. (2011). ES cell-derived renewable and functional midbrain dopaminergic progenitors. Proc Natl Acad Sci U S A, 108:9703–9708.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
